Hafizi, Maryam
Kalanaky, Somayeh
Fakharzadeh, Saideh
Karimi, Pegah
Fakharian, Atefeh
Lookzadeh, Somayeh
Mortaz, Esmaeil
Mirenayat, Maryam Sadat
Heshmatnia, Jalal
Karam, Mehrdad Bakhshayesh
Zamani, Homa
Nadji, Alireza
Toutkaboni, Mihan Pourabdollah
Oraee-Yazdani, Saeed
Akbari, Mohammad Esmaeil
Jamaati, Hamidreza
Nazaran, Mohammad Hassan https://orcid.org/0000-0002-9413-2295
Article History
Received: 8 November 2022
Accepted: 5 September 2023
First Online: 11 November 2023
Declarations
:
: This trial is registered with Iranian Registry of Clinical Trials; Reg. No. IRCT20170731035423N2. It has also received the ethic approval of Shahid Beheshti University of Medical Sciences, Tehran, Iran; Reg. No. IR.SBMU.CRC.REC.1399.001. Consent to participate is not applicable.
: Not applicable.
: Mohammad Hassan Nazaran is the owner of Nanochelating Technology. The authors declare that they have no competing interests.